<DOC>
	<DOCNO>NCT02666742</DOCNO>
	<brief_summary>The purpose study learn take drug call Apixaban ablation procedure keep blood clot form lower chance stroke patient ventricular tachycardia ( VT ) .</brief_summary>
	<brief_title>Safety Efficacy Post Ablation Apixaban Use Reduction Risk Cerebrovascular Events Patients Undergoing Ventricular Tachycardia Radiofrequency Catheter Ablation</brief_title>
	<detailed_description>Ventricular tachycardia ( VT ) fast heart rhythm condition low chamber ( ventricle ) heart beat fast . This condition life threaten ventricle main pump chamber heart . The fast heartbeat cause electrical impulse travel incorrectly heart . One way treat VT catheter ablation procedure . A catheter ablation procedure create scar tissue heart interrupt electrical impulse create irregular heart rhythm . It possible ablation procedure might cause blood clot form . The blood clot stop blood flow brain cause stroke . When blood flow interrupt certain part brain , part receive enough oxygen . As result stroke affect area brain unable function normally . Apixaban ( also know Eliquis ) blood thin drug , also call anticoagulant . It interfere body 's natural blood clot ability inactivate specific enzyme body need form blood clot . Participation study last 30 day .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>Patients undergoing radiofrequency catheter ablation scar VT include VT secondary ischemic cardiomyopathy nonischemic cardiomyopathy Women childbearing potential ( WOCBP ) must negative serum urine pregnancy test within 24 hour prior start study drug Women must breastfeed WOCBP must agree follow instruction method ( ) contraception duration treatment Apixaban plus 33 day posttreatment completion Males sexually active WOCBP must agree follow instruction method ( ) contraception duration treatment total 93 day posttreatment completion Participants must agree use one approve method contraception History cerebral vascular accident/transient ischemic attack ( CVA/TIA ) last 3 month Cardiac surgery neurosurgery within 3 month intend procedure date Any active bleeding Severe hypersensitivity reaction ELIQUIS ( include drug hypersensitivity , skin rash allergic reaction ) Participants prosthetic heart valves History bleed clot disorder Contraindications Aspirin therapy Contraindication oral anticoagulation Patient anticoagulant prior ablation primary indication like atrial fibrillation ( AF ) , deep vein thrombosis ( DVT ) mechanical valve Evidence intracardiac thrombus Patient Creatinine Clearance &lt; 30 cc/min Participation another investigational study related oral anticoagulation , drug and/or device intervention Claustrophobic patient Implantable Cardioverter Defibrillator ( ICD ) generator placement year 2000 Has ICD pace dependent without underlie rhythm upon interrogation baseline Patient abandon lead Patients pglycoprotein inducer inhibitor dose Apixaban effectively alter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>